Prometheus Biosciences Target Price

Explore Prometheus Biosciences's target price with historical charts and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Share Price

$199.92

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2023-04-16	Stifel NicolausAnnabel Samimy	$200	0% upside
2023-01-31	Goldman Sachs	$144	28% downside
2022-12-08	OppenheimerJeff Jones	$125	37.5% downside
2022-12-08	RBC CapitalGregory Renza	$111	44.5% downside
2022-12-08	BTIGJulian Harrison	$181	9.5% downside
2022-12-08	Credit SuisseTiago Fauth	$142	29% downside
2022-12-08	BTIGJulian Harrison	$104.84	47.6% downside
2022-08-28	Piper SandlerYasmeen Rahimi	$67	66.5% downside
2022-06-10	Piper SandlerYasmeen Rahimi	$53	73.5% downside

Prometheus Biosciences (RXDX) FAQ

Stockcircle tracks target price for Prometheus Biosciences (RXDX), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Prometheus Biosciences's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main RXDX overview so you can move from this figure to the surrounding analysis quickly.